1
|
Zhi D, Bai Y, Yang J, Cui S, Zhao Y, Chen H, Zhang S. A review on cationic lipids with different linkers for gene delivery. Adv Colloid Interface Sci 2018; 253:117-140. [PMID: 29454463 DOI: 10.1016/j.cis.2017.12.006] [Citation(s) in RCA: 85] [Impact Index Per Article: 14.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2017] [Revised: 12/19/2017] [Accepted: 12/19/2017] [Indexed: 01/05/2023]
Abstract
Cationic lipids have become known as one of the most versatile tools for the delivery of DNA, RNA and many other therapeutic molecules, and are especially attractive because they can be easily designed, synthesized and characterized. Most of cationic lipids share the common structure of cationic head groups and hydrophobic portions with linker bonds between both domains. The linker bond is an important determinant of the chemical stability and biodegradability of cationic lipid, and further governs its transfection efficiency and cytotoxicity. Based on the structures of linker bonds, they can be grouped into many types, such as ether, ester, amide, carbamate, disulfide, urea, acylhydrazone, phosphate, and other unusual types (carnitine, vinyl ether, ketal, glutamic acid, aspartic acid, malonic acid diamide and dihydroxybenzene). This review summarizes some research results concerning the nature (such as the structure and orientation of linker groups) and density (such as the spacing and the number of linker groups) of linker bond for improving the chemical stability, biodegradability, transfection efficiency and cytotoxicity of cationic lipid to overcome the critical barriers of in vitro and in vivo transfection.
Collapse
|
2
|
Zhi D, Zhang S, Cui S, Zhao Y, Wang Y, Zhao D. The Headgroup Evolution of Cationic Lipids for Gene Delivery. Bioconjug Chem 2013; 24:487-519. [DOI: 10.1021/bc300381s] [Citation(s) in RCA: 188] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Affiliation(s)
- Defu Zhi
- State Key Laboratory of Fine
Chemicals, Dalian University of Technology, Dalian 116012, China
- State Ethnic Affairs Commission-Ministry
of Education Key Laboratory of Biotechnology and Bio-resources Utilization, Dalian Nationalities University, Dalian 116600, China
| | - Shubiao Zhang
- State Ethnic Affairs Commission-Ministry
of Education Key Laboratory of Biotechnology and Bio-resources Utilization, Dalian Nationalities University, Dalian 116600, China
| | - Shaohui Cui
- State Ethnic Affairs Commission-Ministry
of Education Key Laboratory of Biotechnology and Bio-resources Utilization, Dalian Nationalities University, Dalian 116600, China
| | - Yinan Zhao
- State Ethnic Affairs Commission-Ministry
of Education Key Laboratory of Biotechnology and Bio-resources Utilization, Dalian Nationalities University, Dalian 116600, China
| | | | - Defeng Zhao
- State Key Laboratory of Fine
Chemicals, Dalian University of Technology, Dalian 116012, China
| |
Collapse
|
3
|
Mornet E, Carmoy N, Lainé C, Lemiègre L, Le Gall T, Laurent I, Marianowski R, Férec C, Lehn P, Benvegnu T, Montier T. Folate-equipped nanolipoplexes mediated efficient gene transfer into human epithelial cells. Int J Mol Sci 2013; 14:1477-501. [PMID: 23344053 PMCID: PMC3565331 DOI: 10.3390/ijms14011477] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2012] [Revised: 12/31/2012] [Accepted: 01/06/2013] [Indexed: 11/16/2022] Open
Abstract
Since recombinant viral vectors have been associated with serious side effects, such as immunogenicity and oncogenicity, synthetic delivery systems represent a realistic alternative for achieving efficacy in gene therapy. A major challenge for non-viral nanocarriers is the optimization of transgene expression in the targeted cells. This goal can be achieved by fine-tuning the chemical carriers and the adding specific motifs to promote cellular penetration. Our study focuses on the development of novel folate-based complexes that contain varying quantities of folate motifs. After controlling for their physical properties, neutral folate-modified lipid formulations were compared in vitro to lipoplexes leading to comparable expression levels. In addition, no cytotoxicity was detected, unlike what was observed in the cationic controls. Mechanistically, the delivery of the transgene appeared to be, in part, due to endocytosis mediated by folate receptor targeting. This mechanism was further validated by the observation that adding free folate into the medium decreased luciferase expression by 50%. In vivo transfection with the folate-modified MM18 lipid, containing the highest amount of FA-PEG(570)-diether co-lipid (w:w; 90:10), at a neutral charge ratio, gave luciferase transgene expression. These studies indicate that modification of lipids with folate residues could enhance non-toxic, cell-specific gene delivery.
Collapse
Affiliation(s)
- Emmanuel Mornet
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
- Service d’ORL et de chirurgie cervico-faciale, CHU de BREST hôpital Morvan, 2 avenue du maréchal Foch 29609 Brest, France; E-Mail:
| | - Nathalie Carmoy
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
| | - Céline Lainé
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
| | - Loïc Lemiègre
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
| | - Tony Le Gall
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
| | - Isabelle Laurent
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
| | - Remi Marianowski
- Service d’ORL et de chirurgie cervico-faciale, CHU de BREST hôpital Morvan, 2 avenue du maréchal Foch 29609 Brest, France; E-Mail:
| | - Claude Férec
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
| | - Pierre Lehn
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
| | - Thierry Benvegnu
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
| | - Tristan Montier
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
- DUMG – Faculté de médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
- CHRU de Brest, hôpital Morvan, 2 avenue du maréchal Foch 29609 Brest, France
- Author to whom correspondence should be addressed; E-Mail: ; Tel.: +33-2-98-01-80-80; Fax: +33-2-98-01-83-42
| |
Collapse
|
4
|
Berchel M, Le Gall T, Couthon-Gourvès H, Haelters JP, Montier T, Midoux P, Lehn P, Jaffrès PA. Lipophosphonate/lipophosphoramidates: A family of synthetic vectors efficient for gene delivery. Biochimie 2012; 94:33-41. [DOI: 10.1016/j.biochi.2011.07.026] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2011] [Accepted: 07/20/2011] [Indexed: 01/27/2023]
|
5
|
Le Gall T, Loizeau D, Picquet E, Carmoy N, Yaouanc JJ, Burel-Deschamps L, Delépine P, Giamarchi P, Jaffrès PA, Lehn P, Montier T. A Novel Cationic Lipophosphoramide with Diunsaturated Lipid Chains: Synthesis, Physicochemical Properties, and Transfection Activities. J Med Chem 2010; 53:1496-508. [DOI: 10.1021/jm900897a] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
| | - Damien Loizeau
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | - Erwan Picquet
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | | | - Jean-Jacques Yaouanc
- IBiSA SynNanoVect platform
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | - Laure Burel-Deschamps
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | | | - Philippe Giamarchi
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | - Paul-Alain Jaffrès
- IBiSA SynNanoVect platform
- Laboratoire CEMCA, CNRS UMR 6521, IFR 148 ScInBIoS; Université de Bretagne Occidentale, 6 Avenue Le Gorgeu, 29238 Brest, France
| | | | | |
Collapse
|
6
|
Griesenbach U, Alton EWFW. Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy. Adv Drug Deliv Rev 2009; 61:128-39. [PMID: 19138713 DOI: 10.1016/j.addr.2008.09.010] [Citation(s) in RCA: 105] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2008] [Accepted: 09/22/2008] [Indexed: 11/30/2022]
Abstract
Gene therapy is currently being developed for a wide range of acute and chronic lung diseases. The target cells, and to a degree the extra and intra-cellular barriers, are disease-specific and over the past decade the gene therapy community has recognized that no one vector is good for all applications, but that the gene transfer agent (GTA) has to be carefully matched to the specific disease target. Gene therapy is particularly attractive for diseases that currently do not have satisfactory treatment options and probably easier for monogenic disorders than for complex diseases. Cystic fibrosis (CF) fulfils these criteria and is, therefore, a good candidate for gene therapy-based treatment. This review will focus on CF as an example for lung gene therapy, but lessons learned may be applicable to other target diseases.
Collapse
Affiliation(s)
- Uta Griesenbach
- Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College London, Manresa Road, London SW36LR, UK.
| | | |
Collapse
|
7
|
Bhattacharya S, Bajaj A. Advances in gene delivery through molecular design of cationic lipids. Chem Commun (Camb) 2009:4632-56. [DOI: 10.1039/b900666b] [Citation(s) in RCA: 232] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
8
|
Le Gallo M, Toutirais O, Montier T, Cabillic F, Bouet F, Delépine P, Lehn P, Jotereau F, Catros V. Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5. J Gene Med 2008; 10:628-36. [PMID: 18338820 DOI: 10.1002/jgm.1188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Genetic modification of human monocyte-derived dendritic cells (DC) with cDNA sequences encoding tumor-associated antigens (TAA) is a promising strategy for cancer immunotherapy. The present study aimed to develop a nonviral gene transfer method based on the use of the cationic lipophosphoramide reagent, KLN-5, as an alternative to the commonly used viral vectors. METHODS First, the efficiency of KLN5 for gene transfection into DC was investigated using the green fluorescent protein (GFP) reporter gene. The highest transfection efficiency/cell viability ratio was determined by flow cytometry. Next, DC were transfected with a plasmid encoding NY-ESO-1, a TAA expressed in numerous cancers, according to the transfection protocol previously established with the GFP reporter. Transfected DC were then co-cultured with a CD8+ NY-ESO-1 specific HLA-A*02.01 T cell clone to control their ability to correctly process and present the corresponding epitope in the HLA-A*02.01 context. Finally, T cell activation was assessed via flow cytometry-based detection of interferon-gamma production. RESULTS An optimal KLN5/plasmid DNA ratio allowing both significant transgene expression and high viability of DC could be determined. Under the established experimental conditions, antigen processing and presentation of the immunodominant (SLLMWITQC(157-165)) epitope in the HLA-A*0201 context was demonstrated by activation of the NY-ESO-1-specific CD8+ T cell clone. CONCLUSIONS KLN5-based gene transfection into DC allows the efficient induction of TAA presentation and may thus represent a novel attractive nonviral approach for cancer vaccination.
Collapse
Affiliation(s)
- Matthieu Le Gallo
- Université de Rennes 1, Faculté de Médecine, UPRES 3891, Rennes, France
| | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Mével M, Yaouanc JJ, Laurent P, Clément JC, Cartier D, Jaffrès PA, Montier T, Delépine P, Le Gall T, Lehn P, Pichon C, Midoux P, Férec C. Cationic Lipids Based on Phosphonate and Phosphoramidate Chemistry: Synthesis and Application to Gene Therapy. PHOSPHORUS SULFUR 2008. [DOI: 10.1080/10426500701761300] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- Mathieu Mével
- a CEMCA, UMR CNRS 6521, Faculté des Sciences et Techniques , Université de Bretagne Occidentale , Brest, France
| | - Jean-Jacques Yaouanc
- a CEMCA, UMR CNRS 6521, Faculté des Sciences et Techniques , Université de Bretagne Occidentale , Brest, France
| | - Pascale Laurent
- a CEMCA, UMR CNRS 6521, Faculté des Sciences et Techniques , Université de Bretagne Occidentale , Brest, France
| | - Jean-Claude Clément
- a CEMCA, UMR CNRS 6521, Faculté des Sciences et Techniques , Université de Bretagne Occidentale , Brest, France
| | - Dominique Cartier
- a CEMCA, UMR CNRS 6521, Faculté des Sciences et Techniques , Université de Bretagne Occidentale , Brest, France
| | - Paul-Alain Jaffrès
- a CEMCA, UMR CNRS 6521, Faculté des Sciences et Techniques , Université de Bretagne Occidentale , Brest, France
| | - Tristan Montier
- b Unité INSERM 613 “Génétique Moléculaire et Epidémiologie Génétique”, Institut de Synergie des Sciences et de la Santé, Faculté de médecine et des sciences de la santé , Université de Bretagne Occidentale , Brest, France
| | - Pascal Delépine
- b Unité INSERM 613 “Génétique Moléculaire et Epidémiologie Génétique”, Institut de Synergie des Sciences et de la Santé, Faculté de médecine et des sciences de la santé , Université de Bretagne Occidentale , Brest, France
| | - Tony Le Gall
- b Unité INSERM 613 “Génétique Moléculaire et Epidémiologie Génétique”, Institut de Synergie des Sciences et de la Santé, Faculté de médecine et des sciences de la santé , Université de Bretagne Occidentale , Brest, France
| | - Pierre Lehn
- b Unité INSERM 613 “Génétique Moléculaire et Epidémiologie Génétique”, Institut de Synergie des Sciences et de la Santé, Faculté de médecine et des sciences de la santé , Université de Bretagne Occidentale , Brest, France
| | | | | | - Claude Férec
- c Centre de Biophysique Moléculaire , Orléans, France
| |
Collapse
|
10
|
Abstract
Our first review on progress and prospects in cystic fibrosis (CF) gene therapy was published in this series in October 2002. We now summarize the progress made since then and comment on the prospects for CF gene therapy over the next couple of years. Three clinical trials have been carried out, further supporting the proof-of-principle that gene transfer to the airway epithelium is feasible. Developments in viral and non-viral vectors, as well as recent alternative strategies such as gene repair, trans-splicing and stem cell therapy will be reviewed.
Collapse
Affiliation(s)
- U Griesenbach
- Department of Gene Therapy, Imperial College at the National Heart and Lung Institute, London, UK.
| | | | | |
Collapse
|
11
|
Denizot M, Pereira U, Delepine P, Ferec C, Lehn P, Misery L, Montier T. P192 - Les lipophosphoramides cationiques : des vecteurs synthétiques de transfert de gènes efficaces pour la transfection de lignées cellulaires mélanocytaires. Ann Dermatol Venereol 2005. [DOI: 10.1016/s0151-9638(05)79921-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Picquet E, Le Ny K, Delépine P, Montier T, Yaouanc JJ, Cartier D, des Abbayes H, Férec C, Clément JC. Cationic Lipophosphoramidates and Lipophosphoguanidines Are Very Efficient for in Vivo DNA Delivery. Bioconjug Chem 2005; 16:1051-3. [PMID: 16173778 DOI: 10.1021/bc050097k] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Two new families of cationic lipids were designed and synthesized for gene delivery, namely "lipophosphoramidates" and "lipophosphoguanidines", whose efficiency was noteworthy. The most efficient have an arsonium cation as the polar head, and the unsaturated lipidic tails (e.g. oleyl) gave the better in vivo results (mice lungs).
Collapse
Affiliation(s)
- Erwann Picquet
- UMR CNRS 6521, UFR Sciences et Techniques, Université de Bretagne Occidentale, 6, Av. Le Gorgeu, C.S. 93837, F-29238 Brest Cedex 3, France
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Génétique de la mucoviscidose. Rev Mal Respir 2005. [DOI: 10.1016/s0761-8425(05)85589-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
14
|
Montier T, Delépine P, Le Ny K, Fichou Y, Le Bris M, Hardy E, Picquet E, Clément JC, Yaouanc JJ, Férec C. KLN-5: a safe monocationic lipophosphoramide to transfect efficiently haematopoietic cell lines and human CD34+ cells. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2004; 1665:118-33. [PMID: 15471578 DOI: 10.1016/j.bbamem.2004.07.009] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/24/2004] [Revised: 07/19/2004] [Accepted: 07/22/2004] [Indexed: 11/18/2022]
Abstract
The safe and efficient delivery of nucleic acids into haematopoietic stem cells (HSCs) has a wide range of therapeutic applications. Although viruses are being used in most clinical trials owing to their high transfection efficacy, recent results highlight many concerns about their use. Synthetic transfection reagents, in contrast, have the advantage of being safe and easy to manage while their low transfection efficiency remains a hurdle that needs to be addressed before they can be widely used. Using information on transfection mechanisms, a new family of monocationic lipids called lipophosphoramides was synthesized. Their efficiency to transfer genes into haematopoietic cell lines (K562, Jurkat and Daudi) and CD34+ cells was assessed. In this study, we report that one of these new compounds, KLN-5, leads to more efficient transfection activity than one of our previously most efficient reagents (EG-308) and the commercially available monocationic lipids (DC-CHOL and DOTAP/DOPE) (P<0.05). In addition, only a slight toxicity related to the chemical structure of the new compounds is observed. Moreover, we show that KLN-5 can successfully carry the transgene into haematopoietic progenitor cells (CD34+). These results demonstrate that synthetic transfection reagents represent a viable alternative to viruses and could have potential practical utility in a number of applications.
Collapse
Affiliation(s)
- T Montier
- Unité INSERM 613, Institut de Synergie des Sciences et de la Santé, Université de Bretagne Occidentale, avenue Foch, 29609 Brest cedex 2, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|